BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31776465)

  • 21. Transplant Decisions in Patients with Myelofibrosis: Should Mutations Be the Judge?
    Salit RB; Deeg HJ
    Biol Blood Marrow Transplant; 2018 Apr; 24(4):649-658. PubMed ID: 29128551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene expression profiling distinguishes prefibrotic from overtly fibrotic myeloproliferative neoplasms and identifies disease subsets with distinct inflammatory signatures.
    Wong WJ; Baltay M; Getz A; Fuhrman K; Aster JC; Hasserjian RP; Pozdnyakova O
    PLoS One; 2019; 14(5):e0216810. PubMed ID: 31071164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic Risk Assessment in Myeloproliferative Neoplasms.
    Tefferi A; Vannucchi AM
    Mayo Clin Proc; 2017 Aug; 92(8):1283-1290. PubMed ID: 28778261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and molecular features of patients with prefibrotic primary myelofibrosis previously diagnosed as having essential thrombocythemia in Japan.
    Edahiro Y; Araki M; Inano T; Ito M; Morishita S; Misawa K; Fukuda Y; Imai M; Ohsaka A; Komatsu N
    Eur J Haematol; 2019 Jun; 102(6):516-520. PubMed ID: 30977935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary myelofibrosis: 2019 update on diagnosis, risk-stratification and management.
    Tefferi A
    Am J Hematol; 2018 Dec; 93(12):1551-1560. PubMed ID: 30039550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ASXL1/EZH2 mutations promote clonal expansion of neoplastic HSC and impair erythropoiesis in PMF.
    Triviai I; Zeschke S; Rentel J; Spanakis M; Scherer T; Gabdoulline R; Panagiota V; Thol F; Heuser M; Stocking C; Kröger N
    Leukemia; 2019 Jan; 33(1):99-109. PubMed ID: 29907810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update from the latest WHO classification of MPNs: a user's manual.
    Passamonti F; Maffioli M
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):534-542. PubMed ID: 27913526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clonal evolution revealed by whole genome sequencing in a case of primary myelofibrosis transformed to secondary acute myeloid leukemia.
    Engle EK; Fisher DA; Miller CA; McLellan MD; Fulton RS; Moore DM; Wilson RK; Ley TJ; Oh ST
    Leukemia; 2015 Apr; 29(4):869-76. PubMed ID: 25252869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A compendium of cytogenetic abnormalities in myelofibrosis: molecular and phenotypic correlates in 826 patients.
    Wassie E; Finke C; Gangat N; Lasho TL; Pardanani A; Hanson CA; Ketterling RP; Tefferi A
    Br J Haematol; 2015 Apr; 169(1):71-6. PubMed ID: 25521305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative Mutational Profiling of Hematopoietic Progenitor Cells and Circulating Endothelial Cells (CECs) in Patients with Primary Myelofibrosis.
    Farina M; Bernardi S; Polverelli N; D'Adda M; Malagola M; Bosio K; Re F; Almici C; Dunbar A; Levine RL; Russo D
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcriptome Analysis of Monozygotic Twin Brothers with Childhood Primary Myelofibrosis.
    Ding N; Zhang Z; Yang W; Ren L; Zhang Y; Zhang J; Li Z; Zhang P; Zhu X; Chen X; Fang X
    Genomics Proteomics Bioinformatics; 2017 Feb; 15(1):37-48. PubMed ID: 28185911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular Pathogenesis and Clinical Significance of Driver Mutations in Primary Myelofibrosis: A Review.
    Alshemmari SH; Rajan R; Emadi A
    Med Princ Pract; 2016; 25(6):501-509. PubMed ID: 27756071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Array comparative genomic hybridization and sequencing of 23 genes in 80 patients with myelofibrosis at chronic or acute phase.
    Brecqueville M; Rey J; Devillier R; Guille A; Gillet R; Adélaide J; Gelsi-Boyer V; Arnoulet C; Chaffanet M; Mozziconacci MJ; Vey N; Birnbaum D; Murati A
    Haematologica; 2014 Jan; 99(1):37-45. PubMed ID: 23996481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis.
    Barbui T; Thiele J; Vannucchi AM; Tefferi A
    Blood Cancer J; 2015 Aug; 5(8):e337. PubMed ID: 26832847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clonal Hematopoiesis in Myeloproliferative Neoplasms Confers a Predisposition to both Thrombosis and Cancer.
    Barbui T; Gavazzi A; Sciatti E; Finazzi MC; Ghirardi A; Carioli G; Carobbio A
    Curr Hematol Malig Rep; 2023 Aug; 18(4):105-112. PubMed ID: 37221411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis.
    Guglielmelli P; Lasho TL; Rotunno G; Mudireddy M; Mannarelli C; Nicolosi M; Pacilli A; Pardanani A; Rumi E; Rosti V; Hanson CA; Mannelli F; Ketterling RP; Gangat N; Rambaldi A; Passamonti F; Barosi G; Barbui T; Cazzola M; Vannucchi AM; Tefferi A
    J Clin Oncol; 2018 Feb; 36(4):310-318. PubMed ID: 29226763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CCN2/CTGF expression does not correlate with fibrosis in myeloproliferative neoplasms, consistent with noncanonical TGF-β signaling driving myelofibrosis.
    Leguit RJ; Broekhuizen R; de Witte M; Raymakers RAP; Goldschmeding R
    Virchows Arch; 2024 May; 484(5):837-845. PubMed ID: 38602559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased CXCL4 expression in hematopoietic cells links inflammation and progression of bone marrow fibrosis in MPN.
    Gleitz HFE; Dugourd AJF; Leimkühler NB; Snoeren IAM; Fuchs SNR; Menzel S; Ziegler S; Kröger N; Triviai I; Büsche G; Kreipe H; Banjanin B; Pritchard JE; Hoogenboezem R; Bindels EM; Schumacher N; Rose-John S; Elf S; Saez-Rodriguez J; Kramann R; Schneider RK
    Blood; 2020 Oct; 136(18):2051-2064. PubMed ID: 32726410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet-derived growth factor receptor β (PDGFRβ) immunohistochemistry highlights activated bone marrow stroma and is potentially predictive for fibrosis progression in prefibrotic myeloproliferative neoplasia.
    Méhes G; Tzankov A; Hebeda K; Anagnostopoulos I; Krenács L; Bedekovics J
    Histopathology; 2015 Nov; 67(5):617-24. PubMed ID: 25825163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of monocytosis in patients with primary myelofibrosis indicates an accelerated phase of the disease.
    Boiocchi L; Espinal-Witter R; Geyer JT; Steinhilber J; Bonzheim I; Knowles DM; Fend F; Orazi A
    Mod Pathol; 2013 Feb; 26(2):204-12. PubMed ID: 23018876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.